This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignee: National Institute of Advanced Industrial Science and Technology. Active years: 2013-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2016
Title: Ken Nishimura: Innovator in Stem Cell Technology
Introduction
Ken Nishimura is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for generating pluripotent stem cells. With a total of 3 patents, his work has the potential to revolutionize regenerative medicine.
Latest Patents
One of Ken Nishimura's latest patents involves a reprogramming gene-loaded Sendai viral vector. This vector comprises Sendai virus genes and reprogramming genes, which include an NP gene, P/C gene, M gene, F gene, HN gene, and L gene. Notably, at least one of the M gene, F gene, and HN gene is functionally deleted, and the L gene encodes a specific amino-acid sequence. This innovation allows for the production of pluripotent stem cells in a safe manner, as the virus vectors exhibit no cytotoxicity and can sustain gene expression over extended periods.
Another significant patent focuses on producing a persistently infective virus vector. This vector is modified to encode an amino acid sequence that includes a valine substitution at position 1618 in the L protein of a persistently non-infective Sendai virus. The resulting virus vector is non-transmissible yet persistently infective, making it a valuable tool in gene therapy applications.
Career Highlights
Ken Nishimura has worked with esteemed organizations such as the National Institute of Advanced Industrial Science and Technology and the Japan Biological Informatics Consortium. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Throughout his career, Ken has collaborated with notable colleagues, including Mahito Nakanishi and Manami Ohtaka. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Ken Nishimura's work in the field of stem cell technology exemplifies the impact of innovative thinking in biotechnology. His patents not only advance scientific knowledge but also hold promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile